InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

- Current share price for PME : $181.670

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,979 CEO Interview FY25 Results 14 Aug 2025 9:37AM $297.150 $181.670 fallen by 38.86%
$18,979 Dividend/Distribution - PME 14 Aug 2025 9:29AM $297.150 $181.670 fallen by 38.86%
$18,979 2025 Corporate Governance Statement 14 Aug 2025 9:26AM $297.150 $181.670 fallen by 38.86%
$18,979 Appendix 4G 14 Aug 2025 9:25AM $297.150 $181.670 fallen by 38.86%
$18,979 Annual Report 2025 14 Aug 2025 9:25AM $297.150 $181.670 fallen by 38.86%
$18,979 PME Full Year Results 14 Aug 2025 9:22AM $297.150 $181.670 fallen by 38.86%
$18,979 Preliminary Final report FY25 14 Aug 2025 9:20AM $297.150 $181.670 fallen by 38.86%
$18,979 Preliminary Final report FY25 14 Aug 2025 9:20AM $297.150 $181.670 fallen by 38.86%
$18,979 PME signs finance facility with 4DMedical 31 Jul 2025 6:19PM $321.890 $181.670 fallen by 43.56%
$18,979 PME signs finance facility with 4DMedical 31 Jul 2025 6:19PM $321.890 $181.670 fallen by 43.56%
$18,979 4DX:4DMedical secures $10mstrategic invest' from Pro Medicus 31 Jul 2025 4:53PM $321.890 $181.670 fallen by 43.56%
$18,979 4DX:4DMedical secures $10mstrategic invest' from Pro Medicus 31 Jul 2025 4:53PM $321.890 $181.670 fallen by 43.56%
$18,979 PME FY25 Results release date and webcast briefing 7 Jul 2025 8:52AM $307.890 $181.670 fallen by 41%
$18,979 PME signs A$170M, 10-year deal with Colorado-based UCHealth 3 Jul 2025 9:09AM $285.200 $181.670 fallen by 36.30%
$18,979 PME signs A$170M, 10-year deal with Colorado-based UCHealth 3 Jul 2025 9:09AM $285.200 $181.670 fallen by 36.30%
$18,979 PME signs $20M, 5-year contract renewal with FMOL Health 3 Jul 2025 9:07AM $285.200 $181.670 fallen by 36.30%
$18,979 PME signs $20M, 5-year contract renewal with FMOL Health 3 Jul 2025 9:07AM $285.200 $181.670 fallen by 36.30%
$18,979 PME signs A$20M, 5-year contract with UI Health Care 8 May 2025 9:24AM $237.170 $181.670 fallen by 23.40%
$18,979 PME signs Research Collaboration Agreement with UCSF 15 Apr 2025 10:31AM $211.545 $181.670 fallen by 14.12%
$18,979 Notification of cessation of securities - PME 7 Apr 2025 12:12PM $174.600 $181.670 risen by 4.05%
$18,979 Update - Notification of buy-back - PME 7 Apr 2025 12:11PM $174.600 $181.670 risen by 4.05%
$18,979 Notification of cessation of securities - PME 3 Apr 2025 8:21AM $198.810 $181.670 fallen by 8.62%
$18,979 Update - Notification of buy-back - PME 3 Apr 2025 8:21AM $198.810 $181.670 fallen by 8.62%
$18,979 Notification of cessation of securities - PME 2 Apr 2025 8:57AM $199.220 $181.670 fallen by 8.81%
$18,979 Update - Notification of buy-back - PME 2 Apr 2025 8:53AM $199.220 $181.670 fallen by 8.81%

76 - 100 of 669 results

Page 4 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.